• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, October 30, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Herpes zoster linked to faster cognitive decline in older adults

by
October 29, 2026
in Health
Reading Time: 3 mins read
0
Herpes zoster linked to faster cognitive decline in older adults

Herpes zoster linked to faster cognitive decline in older adults

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Older adults who develop herpes zoster — the reactivation of the varicella-zoster virus commonly known as shingles — show faster decline in global cognitive performance afterward, according to a new longitudinal cohort study published in Aging Clinical and Experimental Research. The study, released as open access on 12 October 2026, followed 16,324 older adults who at their individual baseline had no self-reported shingles, no physician-diagnosed dementia, and no severe cognitive impairment. Over up to 12 years of cognitive follow-up, 3,516 participants developed shingles, allowing the researchers to model the infection as a time-varying exposure in mixed-effects statistical models.

The headline result concerned the annual trajectory of a 27-point global cognitive score. Incident shingles was associated with an additional annual decline of 0.06 points on that scale (beta = −0.06; 95% confidence interval −0.08 to −0.05; p < 0.001). The association did not appear to be driven merely by subtle pre-existing illness around the time of diagnosis: when assessments within two years of the shingles event were excluded, the estimated annual decline was, if anything, larger (beta = −0.09; 95% confidence interval −0.12 to −0.07; p < 0.001).

The team also examined clinically meaningful decline, defined as a drop of three points or more on the global cognitive score. In Cox models adjusted for confounders, shingles was associated with a higher risk of such decline (adjusted hazard ratio 1.09; 95% confidence interval 1.04 to 1.15; p < 0.001). By contrast, the adjusted association between incident shingles and a diagnosis of dementia itself was not statistically significant (hazard ratio 1.12; 95% confidence interval 0.92 to 1.35; p = 0.265). In other words, the measurable speeding-up of cognitive decline in the population was not accompanied, in this cohort, by a statistically detectable increase in dementia incidence.

Because the study was framed around psychosocial vulnerability, the researchers also ran secondary and explicitly exploratory analyses on depressive symptoms and sleep burden. Exploratory statistical decompositions testing whether these factors mediated the association yielded nonsignificant results for depressive symptoms (p = 0.144) and for sleep burden (p = 0.515). However, exploratory subgroup analyses identified statistical interactions with both baseline depressive symptoms (p < 0.001) and baseline sleep burden (p = 0.041), with the association between shingles and cognitive decline appearing stronger at higher baseline levels of each. The authors interpret these analyses cautiously: mediation was not supported, but baseline psychosocial burden may modify who is most affected.

The study has several important limitations that should temper interpretation. It is an observational cohort, so the association between shingles and faster cognitive decline does not establish causation, and residual confounding by health status, inflammation, vaccination history, or access to care cannot be excluded. The exposure was based on self-reported shingles, and the cognitive measure is a global composite rather than domain-specific testing. The dementia analysis was also underpowered to detect modest effects, as the wide confidence interval around the non-significant hazard ratio shows. Finally, the results were shared early as a peer-reviewed accepted manuscript that remains subject to further editing before the final Version of Record.

Subject of Research: Longitudinal association between incident herpes zoster and cognitive decline in older adults

Article Title: Incident herpes zoster and accelerated decline in global cognitive performance among older adults: longitudinal trajectories and psychosocial vulnerability

Article References: Qiu, Y., Song, Z., Zhang, R., Wang, Z., & Wang, H. (2026). Incident herpes zoster and accelerated decline in global cognitive performance among older adults: longitudinal trajectories and psychosocial vulnerability. Aging Clinical and Experimental Research. https://doi.org/10.1007/s40520-026-03529-7

Image Credits: AI Generated

DOI: 10.1007/s40520-026-03529-7

Keywords: herpes zoster, shingles, cognitive decline, older adults, cohort study, dementia, depressive symptoms, sleep burden, longitudinal analysis, global cognitive score, Incident, herpes

News Source: Phoebe Ingram. (October 29, 2026). Herpes zoster linked to faster cognitive decline in older adults. Scienmag.

Tags: Cognitive DeclineCohort Studydementiadepressive symptomsglobal cognitive scoreherpesherpes zosterIncidentlongitudinal analysisolder adultsshinglessleep burden
Share12Tweet7Share2ShareShareShare1

Related Posts

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

October 30, 2026
Most Ethiopian HIV patients on dolutegravir therapy show good knowledge, survey finds

Most Ethiopian HIV patients on dolutegravir therapy show good knowledge, survey finds

October 30, 2026

Serum and urine protein biomarkers may sharpen prostate cancer detection beyond PSA

October 30, 2026

One gene locus flags atrial fibrillation risk after major surgery, UK Biobank study finds

October 30, 2026

POPULAR NEWS

  • Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

    Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

    29 shares
    Share 12 Tweet 7
  • Firebreaks Leave Lasting Scars in Grasslands While Wildfire Heals Fast

    29 shares
    Share 12 Tweet 7
  • ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

    29 shares
    Share 12 Tweet 7
  • Systematic review maps sustainability tensions in offshore wind development

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

Firebreaks Leave Lasting Scars in Grasslands While Wildfire Heals Fast

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 86 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.